This article was originally published here

Biomark Res. 2021 Oct 16;9(1):76. doi: 10.1186/s40364-021-00331-7.

ABSTRACT

BACKGROUND: The ten-eleven translocation 1 (TET1) protein is a 5-methylcytosine hydroxylase that belongs to the TET protein family of human -ketoglutarate oxygenases. TET1 recognizes and binds to regions of high genomic 5-CpG-3 dinucleotide density, such as CpG islands, initiates the DNA demethylation program, and maintains DNA methylation and demethylation balance to maintain genomic methylation homeostasis and achieve epigenetic regulation. This article reviews the recent research progress of TET1 in the mechanism of demethylation, stem cells and immunity, various malignant tumours and other clinical diseases.

CONCLUSION: TET1 acts as a key factor mediating demethylation, the mechanism of which still remains to be investigated in detail. TET1 is also critical in maintaining the differentiation pluripotency of embryonic stem cells and plays anti- or oncogenic roles in combination with different signalling pathways in different tumours. In certain tumours, its role is still controversial. In addition, the noncatalytic activity of TET1 has gradually attracted attention and has become a new direction of research in recent years.

PMID:34656178 | DOI:10.1186/s40364-021-00331-7

Read the original:

Advances in the DNA methylation hydroxylase TET1 - DocWire News

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh